Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay L. Goldstein

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Digestion|March 6, 2004
Challenges in managing NSAID-associated gastrointestinal tract injuryJay L Goldstein
Drug, Healthcare and Patient Safety|February 6, 2015
Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategiesJay L Goldstein, Byron Cryer
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Safety and efficacy of lumiracoxib compared with NSAIDsJonathan A Rosenberg, Jay L Goldstein
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2007
Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trialJay L Goldstein, Byron Cryer, Fouad Amer, et al.
The American Journal of Gastroenterology|March 31, 2011
Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERDStephen M Miller, Jay L Goldstein, Lauren B Gerson
Clinical Therapeutics|December 16, 2004
Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysisJay L Goldstein, Bidan Huang, Fouad Amer, et al.
Journal of Medical Economics|January 24, 2013
Healthcare resource utilization and economic impact of a ≥2 g/dL decrease in hemoglobin in osteoarthritis patientsJay L Goldstein, Xuemei Luo, Joseph C Cappelleri, et al.
Current Medical Research and Opinion|July 4, 2007
Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilizationShawn X Sun, Kwan Y Lee, Carl T Bertram, et al.
Journal of Cardiovascular Pharmacology|March 23, 2016
Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and UlcersJay L Goldstein, James M Scheiman, John G Fort, et al.
The American Journal of Gastroenterology|January 6, 2006
Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trialJay L Goldstein, John F Johanson, Lisa J Suchower, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Digestion|March 6, 2004
Challenges in managing NSAID-associated gastrointestinal tract injuryJay L Goldstein
Drug, Healthcare and Patient Safety|February 6, 2015
Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategiesJay L Goldstein, Byron Cryer
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Safety and efficacy of lumiracoxib compared with NSAIDsJonathan A Rosenberg, Jay L Goldstein
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2007
Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trialJay L Goldstein, Byron Cryer, Fouad Amer, et al.
The American Journal of Gastroenterology|March 31, 2011
Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERDStephen M Miller, Jay L Goldstein, Lauren B Gerson
Clinical Therapeutics|December 16, 2004
Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysisJay L Goldstein, Bidan Huang, Fouad Amer, et al.
Journal of Medical Economics|January 24, 2013
Healthcare resource utilization and economic impact of a ≥2 g/dL decrease in hemoglobin in osteoarthritis patientsJay L Goldstein, Xuemei Luo, Joseph C Cappelleri, et al.
Current Medical Research and Opinion|July 4, 2007
Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilizationShawn X Sun, Kwan Y Lee, Carl T Bertram, et al.
Journal of Cardiovascular Pharmacology|March 23, 2016
Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and UlcersJay L Goldstein, James M Scheiman, John G Fort, et al.
The American Journal of Gastroenterology|January 6, 2006
Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trialJay L Goldstein, John F Johanson, Lisa J Suchower, et al.
Pageof 7